ISPD Board of Directors

2018-2020

Officers

 

	President Louise E. Wilkins-Haug, MD, PhD Boston, Massachusetts, USA
	President-Elect Lyn Chitty, PhD, MRCOG London, UK
	Secretary Rossa Chiu, MBBS, PhD, FRCPA Sha Tin, Hong Kong
	Treasurer Sylvie Langlois, MD, CCMG Vancouver, British Columbia, Canada
	Past President Ignatia B. Van den Veyver, MD Houston, Texas, United States

 

Directors

 

	Mahesh Arjandas Choolani, MD, PhD Singapore
	Monique C. Haak, MD, PhD Lieden, Netherlands
	Maria Laura Igarzabal, MD Buenos Aires, Argentina
	Sebastian Illanes, MD, MSc Santiago, Chile
	Francesca Romana Grati, PhD, ErCLG Varese, Italy
	Glenn E. Palomaki, PhD Windham, Maine, USA
	Neeta Lakshmi Vora, MD Chapel Hill, North Carolina, USA Early Career Director

 

Director, Ex-Officio and Editor in Chief, Prenatal Diagnosis

Diana W. Bianchi, MD Bethesda, Maryland, USA

 

ISPD Board of directors in Singapore, September 2019

Position Descriptions 

Director
President
President-Elect
Secretary
Treasurer
Past President

Nominating Committee Chair
SIG Chair

 

Conflict of Interest

ISPD is committed to full transparency regarding its leadership and the potential for conflicts of interest. Each member of the Board of Directors is required annually to review the Conflict of Interest Policy and disclose, in writing, any potential conflicts. As noted in the policy, if a Director has a conflict of interest relating to any matter under consideration for a decision by the Board of Directors, he or she shall abstain from any vote, discussion (except as the remaining Board deems necessary for informational purposes), or any attempt to influence the decision of the Board on that matter. The Board may also require the Director to be excused from a meeting while the matter is being deliberated and voted. Relevant financial or other relationships exist between the following ISPD Board members and the commercial interests listed below:

Diana W. Bianchi, MD
I declare no conflict of interest.
22 March 2018

Rossa W. Chiu, MBBS, PhD, FRCPA
Founder of Xcelom, Cirina and DRA; Equity in GRAIL and DRA; Consultant for GRAIL; Expert panelist of Illumina; Research funding from GRAIL; Patent royalty income from Illumina, Sequenom, Xcelom, GRAIL and DRA
7 March 2018

Sylvie Langlois, MD, CCMG
I was (2013-2017) co-PI on a Genome Canada funded research project that received in kind co-funding from Quiagen, Life Technologies, Perkin Elmer and AriosaDx. I am currently co-PI on a second Genome Canada Funded research project that will receive in kind co-funding from ThermoFisher. I am receiving research funding (operating funds) for a validation study with BioCeryx.
15 March 2018

Glenn E. Palomaki, PhD
Recent independent research grants from Sequenom, Inc., Natera, Inc., and PerkinElmer, Inc. were administered through my employer, Women and Infants Hospital (WIH) of Rhode Island. Consultant fees from Beckman Coulter, PerkinElmer, LabCorp, and Ansh Labs were paid to my employer. Honoraria from Illumina, Roche, and PerkinElmer were paid to my employer. I am a member of the Biochemical and Molecular Genetics Resource Committee of the College of American Pathologists.
13 August 2018

Francesca Romana Grati, PhD
Full-time employee of TOMA laboratory without ownership shares; Scientific advisory board member for Roche; Consultant for Menarini Biomarkers
9 March 2018

Ignatia B. Van den Veyver, MD
I am a member of the scientific advisory board of the Baylor-Genetics Laboratories. This is a for profit diagnostic laboratory that is a joint Venture between Baylor college of Medicine and Miraca Holdings. This is a non-compensated position, hence there is no financial conflict of interest.
18 September 2017

Neeta Lakshmi Vora, MD
I declare no conflict of interest.
20 August 2018

Louise E. Wilkins-Haug, MD, PhD
Genetics Section Editor
2 May 2017